Antiviral therapy in children with hydroa vacciniforme

Acta Dermato-Venereologica

Volumn 89, Issue 4, 2009, Pages 393-397

  Lysell, Josefin ^a   Wiegleb Edström, Désirée ^a   Linde, Annika ^b   Carlsson, Göran ^a   Malmros Svennilson, Johan ^a   Westermark, Anders ^a   Andersson, Jan ^a   Wahlgren, Carl Fredrik ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

Acyclovir; Child; Epstein Barr virus; Lymphoma; Oral ulcer; Photosensitivity; Valacyclovir

Indexed keywords

ACICLOVIR; RITUXIMAB; VALACICLOVIR;

ANTIVIRAL THERAPY; ARTICLE; CASE REPORT; CHILD; EPSTEIN BARR VIRUS; FATIGUE; FEMALE; HUMAN; HYDROA VACCINIFORME; HYPERACTIVITY; IRRITABILITY; LARGE CELL LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MALE; PHOTODERMATOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RASH; RESTLESSNESS; SCHOOL CHILD; SIDE EFFECT; SOMNOLENCE; VIRUS INFECTION; VIRUS LOAD;

ACYCLOVIR; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; DRUG THERAPY, COMBINATION; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; HYDROA VACCINIFORME; JAW DISEASES; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; ORAL ULCER; VALINE;

EID: 69249126747     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0670     Document Type: Article

References (17)

1. Gupta G, Man I, Kemmett D. Hydroa vacciniforme: a clinical and follow-up study of 17 cases. J Am Acad Dermatol 2000;42:208-213. (Pubitemid 30469616)
2. Goldgeier MH, Nordlund JJ, Lucky AW, Sibrack LA, McCarthy MJ, McGuire J. Hydroa vacciniforme: diagnosis and therapy. Arch Dermatol 1982; 118: 588-591.
3. Iwatsuki K, Satoh M, Yamamoto T, Oono T, Morizane S, Ohtsuka M, et al. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders. Arch Dermatol 2006; 142: 587-595. (Pubitemid 43727549)
4. Iwatsuki K, Xu Z, Takata M, Iguchi M, Ohtsuka M, Akiba H, et al. The association of latent Epstein-Barr virus infection with hydroa vacciniforme. Br J Dermatol 1999; 140: 715-721. (Pubitemid 29191396)
5. Ohtsuka T, Okita H, Otsuka S, Yamakage A, Yamazaki S. Hydroa vacciniforme with latent Epstein-Barr virus infection. Br J Dermatol 2001; 145: 509-510. (Pubitemid 32953717)
6. Linde A, Andersson J, Lundgren G, Wahren B. Subclass reactivity to Epstein-Barr virus capsid antigen in primary and reactivated EBV infections. J Med Virol 1987; 21: 109-121. (Pubitemid 17001949)
7. Linde A, Kallin B, Dillner J, Andersson J, Jagdahl L, Lindvall A, et al. Evaluation of enzyme-linked immunosorbent assays with two synthetic peptides of Epstein-Barr virus for diagnosis of infectious mononucleosis. J Infect Dis 1990; 161:903-909. (Pubitemid 20148321)
8. Cho KH, Kim CW, Lee DY, Sohn SJ, Kim DW, Chung JH. An Epstein-Barr virus-associated lymphoproliferative lesion of the skin presenting as recurrent necrotic papulovesicles of the face. Br J Dermatol 1996; 134: 791-796.
9. Magana M, Sangueza P, Gil-Beristain J, Sanchez-Sosa S, Salgado A, Ramon G, et al. Angiocentric cutaneous T-cell lymphoma of childhood (hydroa-like lymphoma): a distinctive type of cutaneous T-cell lymphoma. J Am Acad Dermatol 1998; 38: 574-579. (Pubitemid 28182927)
10. Barrionuevo C, Anderson VM, Zevallos-Giampietri E, Zaharia M, Misad O, Bravo F, et al. Hydroa-like cutaneous T-cell lymphoma: a clinicopathologic and molecular genetic study of 16 pediatric cases from Peru. Appl Immunohistochem Mol Morphol 2002; 10: 7-14. (Pubitemid 34178270)
11. Tynell E, Aurelius E, Brandell A, Julander I, Wood M, Yao QY, et al. Acyclovir and prednisolone treatment of acute infectious mononucleosis: a multicenter, double-blind, placebo-controlled study. J Infect Dis 1996; 174: 324-331. (Pubitemid 26251418)
12. Keever-Taylor CA, Behn B, Konings S, Orentas R, Davies B, Margolis D. Suppression of EBV release from irradiated B lymphoblastoid cell-lines: superior activity of ganciclovir compared with acyclovir. Cytotherapy 2003; 5: 323-335. (Pubitemid 37265000)
13. Balfour HH, Jr., Hokanson KM, Schacherer RM, Fietzer CM, Schmeling DO, Holman CJ, et al. A virologie pilot study of valacyclovir in infectious mononucleosis. J Clin Virol 2007; 39: 16-21.
14. Gruhn B, Meerbach A, Hafer R, Zell R, Wutzler P, Zintl F. Pre-emptive therapy with rituximab for prevention of Epstein-Barr virus-associated lymphoproliferative disease after hematopoietic stem cell transplantation. Bone Marrow Transplant 2003; 31: 1023-1025. (Pubitemid 36722415)
15. Yesudian PD, Sharpe GR. Hydroa vacciniforme with oral mucosal involvement. Pediatr Dermatol 2004; 21: 555-557.
16. Rhodes LE, White SI. Dietary fish oil as a photoprotective agent in hydroa vacciniforme. Br J Dermatol 1998; 138: 173-178.
17. Slots J, Saygun I, Sabeti M, Kubar A. Epstein-Barr virus in oral diseases. J Periodontal Res 2006; 41: 235-244.